Skip to content

SCAN Memory Program Evaluation Study

SCAN Memory Program Evaluation Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01182987
Acronym
SMPES
Enrollment
500
Registered
2010-08-17
Start date
2009-10-31
Completion date
2012-03-31
Last updated
2010-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Keywords

Quality improvement, Quality of care, Health care utilization, Behavioral change

Brief summary

The SCAN Memory Program Evaluation study is an evaluation of a randomized controlled trial intervention consisting of a care management program for cognitively-impaired health plan members and for their informal/family caregivers. The program includes collaboration between the health plan, partnering medical groups, and community organizations. Program activities include: 1) telephonic-structured assessments with informal caregivers conducted by SCAN Memory Program care managers; 2) problem identification as a result of these assessments; and 3) pre-established protocols and procedures for problem resolution. ACCESS, the prototype for the SCAN Memory Program, was developed and tested in San Diego County and was very successful in helping affected patients and their caregivers.

Interventions

The SCAN Memory Program is a care management program for cognitively-impaired SCAN members and for their informal/family caregivers. The program includes collaboration between SCAN Health Plan, partnering medical groups, and community organizations. Program activities include: 1) telephonic-structured assessments with informal caregivers conducted by SCAN Memory Program care managers; 2) problem identification as a result of these assessments; and 3) pre-established protocols and procedures for problem resolution.

Sponsors

University of California, Los Angeles
CollaboratorOTHER
VA Greater Los Angeles Healthcare System
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Health plan member eligibility includes having a visit-based ICD-9 diagnostic code for dementia or a dementia-specific medication (including donepezil, rivastigmine, galantamine, and memantine) within administrative data any time prior to data inquiry for potential subjects. The health plan member must have a caregiver who can communicate by telephone and though that person might also be a health plan member, health plan membership for caregivers is not required. All subjects must be living in the community and if in a nursing facility, this must be for rehabilitation or respite care but not for long term care. Caregivers must be able to communicate in English or Spanish.

Exclusion criteria

Person with dementia whose potential participation is declined by their physician. Those who do not have a family or informal caregiver cannot participate and caregivers who do no have telephone access or the capacity to consent to research evaluation are excluded. Patients who reside in nursing facilities as permanent residents are not eligible. \-

Design outcomes

Primary

MeasureTime frameDescription
Guideline Adherence18 months of longerQuality of care process measures will be examined that reflect practice guideline quality indicators measuring patient and caregiver assessment, treatment, education and support, and safety. Measures are collected at 9 and 18 months using caregiver surveys and medical record abstraction.
Program feasibility and fidelity6 to 18 monthsFormative Evaluation consisting of a series of stakeholder semi-structured interviews and data abstraction to monitor the activities of healthplan care managers will be collected at pre-specificed intervals and results will be provivided periodically to the healthplan for ongoing improvements in program delivery.
Healthcare utilization18 monthsCaregiver specific utilization including use of services that care managers may recommend to them and the dementia patient. Emergency department, hospitalization and ambulatory visits data will also be collected through administrative data and caregiver surveys.

Secondary

MeasureTime frameDescription
Quality of Care9 and 18 monthsUsing caregiver surveys, this will be measured with a 5-item scale from the Consumer Assessment of Health Plans Survey 2.0.
Caregiver self-efficacy9 months and 18 monthscaregiver confidence using a 6-item measure that was utilized in prior care management clinical trials
Caregiver unmet need for assistance9 months and 18 monthsa 2-item, 3-point scale for each covering general caregiveing - bathing, dressing, and transportation
Behavioral disturbance9 months and 18 monthsNeuropsychiatric inventory questionnaire (NPI-Q)as a caregiver derived assessment on caregiver surveys conducted at baseline, 9 and 18 months.
Caregiver burden9 months and 18 monthsThe 22-item Burden Interview is a widely used validated measure to assess stressors experienced by caregivers of persons with dementia. Each itme uses a 5-point scale (response set).
Caregiver depression9 months and 18 monthsThe Patient Health Questionnaire - Nine (PHQ-9) will be included in caregiver surveys at baseline, 9 and 18 months as a measure of depressive symptoms over the preceding 2 weeks.
Caregiver social support9 months and 18 monthsThis will be measured in caregiver surveys using a 5-item measure derived from the Medical Outcomes study Social Support Survey (MSSS).
Functional Status9 and 18 monthsUsing an informant (caregiver)-based measure of 10 complex higher order activities using the Functional Activities Questionnaire (FAQ). This is a reliable measure of functional status in patients with dementia.
Quality of life9 and 18 monthsPatient health related quality of life (HRQOL) using the Health Utilities Index

Countries

United States

Contacts

Primary ContactJoshua Chodosh, MD, MSHS
jchodosh@mednet.ucla.edu310-268-3361
Backup ContactKaren Connor, RN, MBA, PhD
kiconnor@ucla.edu310-268-3975

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026